GT Biopharma, Inc. (GTBP) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

greetings and welcome to the gt biopharma second quarter 2021 conference call all participants are currently in a listen-only mode following the formal presentation we'll open the call up for a question and answer session at this time i'd like to turn the conference call over to david castaneda investor relations for the company thank you you may proceed thank you operator good morning everyone and welcome to gt biopharma's second quarter 2021 conference call Earlier this morning, we issued a press release summarizing the company's second quarter 2021 corporate updates that management will discuss on the call today. You can access the press release by going to the news and media section and then the press releases page on our website at gtbiopharma.com. GT Biopharma's following presentation and ensuing question and answer session will include statements that are or may be deemed forward-looking statements. In some cases, you can identify forward-looking statements by terminology, including anticipates, believes, can, continue, could, estimates, expects, intends, may, plans, potential, predicts, should, will, would, or is negative thereof. Other variations thereon are other comparable terminology. We operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this presentation may not occur and actual results c...